Artelo Biosciences Inc Ownership
$3.26
3.26%
Nasdaq, Oct 09, 04:00 pm EDT.
Closed.
Index
Industry
Artelo Biosciences Inc Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Jane Street Capital, L.L.C.
|
7.371k | 0.18% | +5.918k | Jun 30 2026 |
| 2 |
Geode Capital Management, L.L.C.
|
1.540k | 0.04% | +1.540k | Jun 30 2026 |
| 3 |
StoneX Group Inc.
|
1.378k | 0.03% | +1.378k | Jun 30 2026 |
| 4 |
Vanguard Capital Management, LLC
|
1.125k | 0.03% | — | Jun 30 2026 |
| 5 |
Tower Research Capital LLC
|
937.000 | 0.02% | +623.000 | Jun 30 2026 |
|
1
Jane Street Capital, L.L.C.
|
0.18%
7.371k
|
|
2
Geode Capital Management, L.L.C.
|
0.04%
1.540k
|
|
3
StoneX Group Inc.
|
0.03%
1.378k
|
|
4
Vanguard Capital Management, LLC
|
0.03%
1.125k
|
|
5
Tower Research Capital LLC
|
0.02%
937.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 0.29% of Artelo Biosciences Inc, with Jane Street Capital, L.L.C. the biggest at 0.18%, followed by Geode Capital Management, L.L.C. (0.04%) and StoneX Group Inc. (0.03%). |
Artelo Biosciences Inc Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Artelo Biosciences Inc has held steady at around 4.1% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
